GoingToMeet

Now entering its eighth year, IBC's Formulation Strategies for Protein Therapeutics is a must-attend conference each year for formulation, delivery and analytical development scientists from biotherapeutic development organizations from around the world.

* Understand how to optimize formulations for pre-filled syringe products from early development to commercialization with strategies from Amgen, Biogen-Idec, Human Genome Sciences, Merck, West Pharmaceutical Services and the U.S. Food and Drug Administration
* Learn how to design quality into your protein therapeutics from the start in an important panel, "The QbD Pioneers: Perspectives from Companies that have Implemented Quality by Design Concepts in Formulation Development"
* Overcome the challenges of formulating high concentration proteins – with case studies from Abbott Laboratories, Amgen, Genentech, Roche and Wyeth
* Benchmark your formulation operation in a facilitated small group Best Practices Exchange for formulation scientists